Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES GLENMARK PHARMA ALKEM LABORATORIES/
GLENMARK PHARMA
 
P/E (TTM) x 37.5 -31.4 - View Chart
P/BV x 6.5 2.9 228.6% View Chart
Dividend Yield % 1.0 0.3 387.6%  

Financials

 ALKEM LABORATORIES   GLENMARK PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
GLENMARK PHARMA
Mar-23
ALKEM LABORATORIES/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs3,625487 744.2%   
Low Rs2,835349 812.6%   
Sales per share (Unadj.) Rs970.1460.4 210.7%  
Earnings per share (Unadj.) Rs84.213.4 629.6%  
Cash flow per share (Unadj.) Rs110.235.0 314.4%  
Dividends per share (Unadj.) Rs50.002.50 2,000.0%  
Avg Dividend yield %1.50.6 258.8%  
Book value per share (Unadj.) Rs756.4335.1 225.7%  
Shares outstanding (eoy) m119.57282.17 42.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.30.9 366.7%   
Avg P/E ratio x38.431.3 122.7%  
P/CF ratio (eoy) x29.311.9 245.8%  
Price / Book Value ratio x4.31.2 342.3%  
Dividend payout %59.418.7 317.7%   
Avg Mkt Cap Rs m386,207117,953 327.4%   
No. of employees `000NANA-   
Total wages/salary Rs m21,31427,810 76.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,993129,901 89.3%  
Other income Rs m2,1613,168 68.2%   
Total revenues Rs m118,153133,069 88.8%   
Gross profit Rs m15,06515,125 99.6%  
Depreciation Rs m3,1046,113 50.8%   
Interest Rs m1,0743,496 30.7%   
Profit before tax Rs m13,0488,685 150.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9804,911 60.7%   
Profit after tax Rs m10,0683,774 266.8%  
Gross profit margin %13.011.6 111.5%  
Effective tax rate %22.856.5 40.4%   
Net profit margin %8.72.9 298.8%  
BALANCE SHEET DATA
Current assets Rs m86,06498,737 87.2%   
Current liabilities Rs m37,07150,455 73.5%   
Net working cap to sales %42.237.2 113.6%  
Current ratio x2.32.0 118.6%  
Inventory Days Days337 486.5%  
Debtors Days Days67115 58.3%  
Net fixed assets Rs m37,24576,920 48.4%   
Share capital Rs m239282 84.7%   
"Free" reserves Rs m90,20894,281 95.7%   
Net worth Rs m90,44794,563 95.6%   
Long term debt Rs m038,521 0.0%   
Total assets Rs m124,541175,658 70.9%  
Interest coverage x13.23.5 377.5%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 125.9%   
Return on assets %8.94.1 216.2%  
Return on equity %11.14.0 278.9%  
Return on capital %15.69.2 170.6%  
Exports to sales %14.60-   
Imports to sales %00-   
Exports (fob) Rs m16,916NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m16,91646,464 36.4%   
Fx outflow Rs m4,19012,712 33.0%   
Net fx Rs m12,72733,751 37.7%   
CASH FLOW
From Operations Rs m16,8256,254 269.0%  
From Investments Rs m1,128-5,285 -21.4%  
From Financial Activity Rs m-17,608-775 2,273.3%  
Net Cashflow Rs m416325 128.1%  

Share Holding

Indian Promoters % 56.7 46.7 121.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.4 34.7 70.4%  
FIIs % 8.5 23.7 35.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 53.4 81.1%  
Shareholders   65,184 209,931 31.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Glenmark Pharma Share Price Performance

Period ALKEM LABORATORIES Glenmark Pharma S&P BSE HEALTHCARE
1-Day -1.18% -0.57% 1.18%
1-Month -0.99% 5.16% -0.75%
1-Year 52.26% 112.94% 61.82%
3-Year CAGR 21.70% 27.51% 18.16%
5-Year CAGR 22.99% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.